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In budding yeast, commitment to DNA replication during the normal cell cycle requires degradation of the cyclin-dependent kinase (CDK)
inhibitor Sic1. The G1 cyclin–CDK complexes Cln1–Cdk1 and Cln2–Cdk1 initiate the process of Sic1 removal by directly catalyzing Sic1
phosphorylation at multiple sites. Commitment to DNA replication during meiosis also appears to require Sic1 degradation, but the G1 cyclin–
CDK complexes are not involved. It has been proposed that the meiosis-specific protein kinase Ime2 functionally replaces the G1 cyclin–CDK
complexes to promote Sic1 destruction. To investigate this possibility, we compared Cln2–Cdk1 and Ime2 protein kinase activities in vitro. Both
enzyme preparations were capable of catalyzing phosphorylation of a GST–Sic1 fusion protein, but the phosphoisomers generated by the two
activities had significantly different electrophoretic mobilities. Furthermore, mutation of consensus CDK phosphorylation sites in Sic1 affected
Cln2–Cdk1- but not Ime2-dependent phosphorylation. Phosphoamino acid analysis and phosphopeptide mapping provided additional evidence
that Cln2–Cdk1 and Ime2 targeted different residues within Sic1. Examination of other substrates both in vitro and in vivo also revealed differing
specificities. These results indicate that Ime2 does not simply replace G1 cyclin–CDK complexes in promoting Sic1 degradation during meiosis.
© 2006 Elsevier B.V. All rights reserved.Keywords: Cyclin-dependent kinase; G1 cyclin; Meiosis; Phosphorylation; Replication protein A; Sic11. Introduction
Progression into the DNA synthetic (S) phase of the cell
cycle is a critical transition that is often defective in cancer cells.
Studies in a variety of systems have revealed that precise
regulation of cyclin-dependent kinase (CDK) activation con-
trols S phase entry. In the budding yeast Saccharomyces
cerevisiae, many of the molecular details underlying this
regulation have been elucidated. Central components are the
cyclin–CDK complexes Clb5– and Clb6–Cdk11 [1]. These
protein kinases are held inactive in G1 by Sic1, a CDK inhibitor
that is specific for B-type cyclin–CDK complexes [2]. At the
G1/S transition, the G1 cyclin–CDK complexes Cln1– and
Cln2–Cdk1 catalyze Sic1 phosphorylation at multiple CDK
consensus phosphorylation sites to promote Sic1 removal
through ubiquitin-mediated proteolysis [3–7]. Consequently,
the Clb5– and Clb6–Cdk1 complexes become active and DNA⁎ Corresponding author. Tel.: +1 313 833 0715; fax: +1 313 832 7294.
E-mail address: brushg@karmanos.org (G.S. Brush).
1 Cdk1 is also known as Cdc28.
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doi:10.1016/j.bbamcr.2006.10.003replication ensues. These Cdk1 complexes also contribute to
prevention of DNA re-replication (see [8] for review), and loss
of this control ultimately activates a Mec1-dependent check-
point pathway that responds to genotoxic stress [9].
DNA replication is not limited to proliferating cells, but also
occurs during meiosis as a precursor to the two rounds of
chromosome segregation that lead to generation of haploid
gametes. As is the case during the mitotic cell cycle, Clb5, Clb6,
and Cdk1 are required for proper meiotic S phase entry [10–12].
It is likely that meiotic Clb5– and Clb6–Cdk1 complexes act
similarly to mitotic Clb5– and Clb6–Cdk1 complexes in pro-
moting DNA replication. Whether they are also involved in
preventing DNA re-replication during meiosis is not known.
However, overexpression of Clb5 during meiosis stimulates
DNA re-replication, a phenotype that would not be expected
based onmitotic studies [13]. As in proliferating cells, regulation
of Clb5– and Clb6–Cdk1 activities in early meiosis appears to
involve Sic1 because it disappears as cells enter meiotic S phase
[10]. However, the G1 cyclins inhibit meiotic entry [14] and
Cdk1 itself is not required for Sic1 removal [12]. Therefore, a
different mechanism must operate to relieve Sic1 inhibition
Fig. 1. Protein expression. (A) Western blot analysis of Ime2TFT and Cln2TFT
using antibody directed against HA. Crude extracts were prepared from cells
grown in glucose (glu) or alternatively in galactose (gal), which induced
expression of the tagged enzymes. The same membrane was probed with anti-
tubulin for loading comparison. (B) Western blot analysis of Rfa2. The same
extracts used in A were analyzed for Rfa2 using specialized gel conditions to
resolve unphosphorylated (U) and phosphorylated (P) species [27]. As in A, the
same membrane was probed with anti-tubulin for loading comparison.
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nase replaces the G1 cyclin–Cdk1 complexes, catalyzing phos-
phorylation of the same sites to initiate Sic1 degradation. It has
been proposed that the protein kinase Ime2 fulfills this role [10].
Ime2 is induced early in meiosis and is required for normal
meiotic progression into S phase [15–17]. Ime2 and Cdk1 have
been placed in the same general group of related protein kinases
based on sequence analysis of their catalytic domains [18], perhaps
suggesting that the two enzymes recognize commonmotifs. In the
absence of Ime2, Sic1 does not disappear during meiosis; further-
more, the meiotic S phase entry defect of Ime2-deficient cells is
rescued by deletion of Sic1 [10]. In addition, over-expression of a
Sic1 mutant that is altered at several Cdk1 consensus phosphory-
lation sites prevents meiotic S phase entry [11]. Therefore,
considerable evidence supports the hypothesis that Ime2 serves as
a G1 cyclin–Cdk1 replacement duringmeiosis. However, we have
recently found that Ime2 catalyzes phosphorylation of a non-Cdk1
consensus phosphorylation site in replication protein A (RPA)
[19]. This observation prompted us to determine whether Ime2
catalyzes Sic1 phosphorylation in amanner similar to Cln2–Cdk1.
We have found that the two enzymes display different specificities,
indicating that other possible mechanisms underlyingmeiotic Sic1
disappearance should be considered.
2. Materials and methods
2.1. Enzyme induction
Yeast strains capable of expressing tandem fusion tagged (TFT) versions of
Cln2 and Ime2 were purchased from Open Biosystems. In these cells, a GAL1
promoter drives gene expression from a URA3-containing high copy plasmid
leading to generation of protein with tandem hexa-histidine (6xHis),
hemagglutinin (HA), and protein A tags at the C terminus [20]. All yeast
growth was conducted at 30 °C. Cells were inoculated into synthetic complete
medium lacking uracil containing 2% raffinose at a low density and incubated
overnight until an A600 of ∼1.0 was reached. Nutrient rich media was then
added to bring final concentrations of yeast extract to 1%, peptone to 2%, and
either glucose or galactose to 2%. Incubation was continued to achieve an
approximate doubling in population.
2.2. Extract preparation and fractionation
Native crude extracts were prepared by bead beating. Harvested cell pellets
were suspended in lysis buffer (LyB) (50 mMTris–Cl pH 7.5, 0.1% NP-40, 10%
glycerol, 250 mM NaCl, 0.1 mM PMSF, 1 mg/ml leupeptin, 1 mg/ml pepstatin
A), and an approximately equal volume of acid-washed glass beads (Sigma) was
added. The cells were disrupted by vortexing a total of 10 times for 20 sec each,
with 1 min intermittent incubations on ice. Resulting lysates were clarified by
centrifugation at 18,000×g for 10 min at 4 °C. Extracts were fractionated in
batch with Talon Metal Affinity Resin (BD Biosciences) using imidazole for
elution. Protein concentrations of lysates and purified fractions were measured
by the Bradford assay [21] (Bio-Rad) with bovine serum albumin as the
standard. Western blot analyses were conducted using the fluorescence-scanning
Odyssey system and its associated software (LiCor). Primary antibodies
included HA-11 monoclonal (Covance), rabbit anti Rfa2 polyclonal [22], and rat
anti α-tubulin polyclonal (Serotec). Signals were generated with IRDye 800-
conjugated goat anti-mouse or-rabbit secondary antibodies (Rockland) or Alexa
Fluor 680 goat anti-rat secondary antibody (Invitrogen).
2.3. Sic1 generation and purification
Plasmids encoding Sic1 derivatives with HA and 6xHis tags at the C-
terminus were kindly provided by Raymond Deshaies. One version, referred tohere simply as Sic1, is degraded properly during vegetative growth; the other,
referred to here as Sic1ΔP, is resistant to degradation during vegetative growth
due to mutations of multiple Cdk1-targeted phosphorylation sites [5]. Both Sic1
and Sic1ΔP contain a T2A mutation, while Sic1ΔP contains additional T5GP,
T33A, and S76A mutations. The two SIC1 genes were individually cloned into
pIVEX-GST (Roche) for production of glutathione-S-transferase (GST) fusion
proteins. Versions encoding GST-Sic1 mutated from serine to alanine at
positions corresponding to Sic1 145 (S145A) or 201 (S201A) were generated
from the pIVEX-GSTconstruct containing SIC1 using QuikChange (Stratagene)
methodology. The pIVEX-GST-based plasmids were introduced into E. coli
BL21(DE3) and expression of the GST-tagged Sic1 derivatives was induced in
these cells by exposure to IPTG. Purification was accomplished through
glutathione-agarose (Pierce) affinity chromatography using glutathione for
elution followed by Mono Q (Pharmacia) ion-exchange chromatography.
Protein concentrations were measured as described above.
2.4. Protein and peptide kinase assays
Phosphorylation reactions designed to compare Cln2–Cdk1 and Ime2
activities in vitro were conducted with solid phase enzyme fractions and soluble
substrates. For experiments shown in Figs. 2–4, Talon eluates (see above) were
prepared from the crude extracts analyzed in Fig. 1A and mixed with IgG
Sepharose beads (Amersham) in LyB at 3.5 mg protein per ml of beads for 2 hr at
4 °C. For the experiments shown in Figs. 5 and 6, Talon eluates were prepared
from different crude extracts than those used previously. Based on analysis of
enzyme induction and histone H1 kinase activity, we elected to maintain the
above conditions for generation of the Cln2TFT–IgG fractionwhile incubating the
Ime2TFT Talon eluate with IgG Sepharose at either 7 mg (Figs. 5 and 6) or 14 mg
Fig. 2. Histone H1 kinase activity. Protein kinase assays were conducted with
purified histone H1 serving as substrate. Enzyme fractions were prepared from
cells harboring plasmid encoding either Ime2TFT or Cln2TFT grown under non-
inducing (glu) or inducing (gal) conditions. Relative levels of Ime2TFT and
Cln2TFT employed in the kinase assays were analyzed through separate western
blot analysis of the enzyme fractions (upper panel). Incorporation of radioactive
phosphate into H1 was detected and quantified by phosphorimaging analysis
(lower panel). Values shown indicate relative incorporation into histone H1 and
have been normalized to the sample containing the uninduced Ime2 enzyme
fraction (lane 1).
452 K.E. Sawarynski et al. / Biochimica et Biophysica Acta 1773 (2007) 450–456(Fig. 5) protein per ml beads. In all cases, the beads were then washed twice with
LyB and twice with 10 mM HEPES pH 7.4, 10 mMMgCl2, 1 mM DTT. Protein
kinase assays were conducted with 5 μl washed beads in a final volume of 20 μl
containing 15 mM HEPES pH 7.4, 15 mMMgCl2, 12.5 μMATP, and ∼2.5 μCi
[γ-32P]ATP. Where indicated, either 1 μg of calf thymus histone H1 (Sigma),
GST–Sic1, GST–Sic1ΔP, GST–Sic1S145A, or GST–Sic1S201A was added. The
samples were incubated at 30 °C for 40 min and then subjected to electrophoresis
through a 10% SDS-polyacrylamide gel. Proteins were stained with GelCode
Blue Stain Reagent (Pierce), and incorporation of radioactive phosphate was
detected by phosphorimaging analysis of the dried gel. Similar reaction
conditions were used to test casein kinase II-catalyzed phosphorylation of the
GST–Sic1 fusion proteins except that soluble enzyme (New England BioLabs)
was used and samples were incubated at 30 °C for 10 min. For peptide kinase
assays, 5 μl washed beads were combined with 40 μl buffer containing 10 mM
HEPES pH 7.4, 10 mMMgCl2, 1 mMDTT, 100 μMATP,∼0.2 μCi [γ-32P]ATP,
and, where indicated, 1 mM peptide SRPGSGER or peptide SRPGAGER
(EZBiolab). Samples were incubated at 30 °C for 30 min and the reactions were
stopped by addition of 5 μl 0.5M EDTA. Incorporation of radioactive phosphate
into peptides was monitored through liquid scintillation spectrometry of peptides
bound to phosphocellulose paper (see ref. [23]).
2.5. Phosphoamino acid analysis and phosphopeptide mapping
Two dimensional phosphoamino acid analysis and phosphopeptide
mapping were conducted according to previously described protocols
[24,25]. Sic1 phosphoisomers generated in vitro were subjected to
electrophoresis, transferred to a polyvinylidene fluoride membrane, and
excised. The membranes were then incubated with 0.5% polyvinyl pyrro-
lidone in 100 mM acetic acid for 30 min at 37 °C and washed extensively. The
Sic1 phosphoisomers were then digested with 5 μg of sequencing grademodified
trypsin (Promega) in 50 mM ammonium bicarbonate for 2 h at 37 °C and with an
additional 5 μg of trypsin overnight. Eluted peptides were oxidized with
performic acid and subsequently washed with pH 1.9 thin layer chromatography
(TLC) buffer (see [24]). Aliquots of the samples were used for phosphoamino
acid analysis. Peptides were hydrolyzed in 6 N HCl at 111 °C for 1 hr and
phosphoamino acids were resolved on cellulose TLC plates (Merck) by electro-
phoresis in two dimensions. 32P-labeled amino acids were visualized by phos-
phorimaging and identified by reference to ninhydrin-stained phosphoamino acid
standards. Separate aliquots were used for phosphopeptide mapping. Peptides
were spotted on cellulose TLC plates and separated using the Hunter thin layer
electrophoresis system (CBS Scientific) in pH 1.9 buffer at 1250 V for 30 min.
The plates were dried overnight and subjected to second dimension chromato-
graphic separation in a phospho-chromatography buffer (see [24]). The plates
were dried and phosphopeptide spots were visualized by phosphorimaging.
3. Results and discussion
To compare Cln2–Cdk1 and Ime2 kinase activities, we
employed identically tagged versions of Cln2 and Ime2 to
generate fractions enriched for these and associated proteins
(see Materials and methods). Plasmids encoding these proteins
(Cln2TFT and Ime2TFT) were harbored in the same strain
background, and expression was controlled by the galactose-
inducible GAL1 promoter. Western blot analysis revealed
comparable levels of the two identically tagged proteins
specifically in cells exposed to galactose (Fig. 1A). Consistent
with our earlier studies [26], we observed extensive phosphor-
ylation of the RPA middle subunit (Rfa2) upon induction of
Ime2TFT. In uninduced cells, a low level of phosphorylated Rfa2
was observed (Fig. 1B, lanes 1 and 3). We have previously
shown that Mec1 catalyzes Rfa2 phosphorylation during the
normal cell cycle to generate this species [27]. Ime2TFT
induction generated a predominant Ime2-dependent phosphory-
lated form of Rfa2 and a second Ime2- and Mec1-dependentform (Fig. 1B, lane 2). Such an effect was not observed upon
induction of Cln2TFT (Fig. 1B, lane 4). It is noted that the
version of Cln2 that we employed in these studies was fully
functional based on our in vitro studies (see below). We recently
reported that Ime2 directly catalyzes Rfa2 phosphorylation at a
single site that is not typically recognized by CDK complexes,
and that mutation of this site abolishes the alteration in Rfa2
mobility that accompanies Ime2 induction [19]. Our new results
here suggest that Cln2–Cdk1 does not recognize this site in
vivo, a conclusion that is supported by further data presented
below.
Cln2TFT and Ime2TFT were purified from crude cell extracts
through a two step procedure that took advantage of the tandem
tags (see Materials and methods). The tagged proteins in the
final fraction could not be detected by silver staining, but
relative levels were compared by western blot analysis (Fig. 2,
upper panel). For control purposes, identical fractionation was
conducted with extracts from cells in which expression was not
induced. The isolates containing either Cln2TFT or Ime2TFT
exhibited significant histone H1 kinase activity (Fig. 2, lower
panel). We repeatedly noticed a difference in the electrophoretic
migration of the phosphorylated histone H1 products that were
generated by Cln2TFT- and Ime2TFT-associated activities. These
results suggest a disparity in the specificity of the two enzymes,
given that the overall level of histone H1 phosphorylation that
we observed was comparable in the two cases.
Because Rfa2 was differentially phosphorylated in vivo upon
expression of Cln2TFT or Ime2TFT, we elected to examine the
activities of the two enzymes using a peptide substrate relevant
to Rfa2. We showed previously that the peptide SRPGSGER
containing the sequence immediately surrounding Rfa2 serine
27 (S27) serves as a substrate of Ime2 while the “mutant”
peptide SRPGAGER does not [19]. We tested these two
peptides as substrates using the same fractions that were
Fig. 3. Peptide kinase activity. Enzyme fractions from the same extracts employed in the histone H1 kinase assay were tested for their ability to catalyze
phosphorylation of a peptide derived from Rfa2 (S27) or its mutant derivative (A27).
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found that only the Ime2TFT-containing fraction catalyzed
phosphorylation in an S27-dependent manner (Fig. 3). These
results indicate that the S27 peptide does not serve as a general
protein kinase substrate and provide further evidence that Cln2–
Cdk1 and Ime2 recognize different sequences. It is important to
add that Rfa2 S27 is recognized by Ime2 during meiosis [19].
Therefore, the Ime2TFT that we purified from mitotic cells
behaved like meiotic Ime2 with respect to at least one of its
natural substrates.
To specifically determine whether Ime2 is capable of
replacing Cln2–Cdk1 as a Sic1 kinase, we tested the two
enzyme preparations for Sic1 phosphorylation in vitro. For
this purpose, we employed two purified GST versions of Sic1:
one derived from a Sic1 protein that is degraded efficiently in
vegetative cells (GST–Sic1), and the other derived from a
Sic1 protein that is not degraded in vegetative cells due to
multiple alterations of Cdk1-targeted phosphorylation sitesFig. 4. Sic1 kinase activity. Purified GST-tagged versions of Sic1 and Sic1ΔP were tes
fractions that had been tested for histone H1 kinase activity. Incorporation of radioac
panel). Values shown indicate relative incorporation into Sic1 derivatives and have be
GST–Sic1 (lane 7). Higher molecular weight radioactive species are presumed to b
samples was visualized by Coomassie staining (lower panel).(GST–Sic1ΔP) (see ref. [5] and Materials and methods).
Neither kinase preparation catalyzed appreciable phosphoryla-
tion of GST alone (data not shown). However, we found that
Cln2TFT-associated activity catalyzed GST–Sic1 phosphoryla-
tion, leading to multiple phosphoisomers with reduced
electrophoretic mobility (Fig. 4, lane 10). In contrast, GST–
Sic1ΔP was phosphorylated with 50% efficiency compared to
GST–Sic1 and the resulting GST–Sic1ΔP phosphoisomers had
significantly higher electrophoretic mobility on average than
the GST–Sic1 phosphoisomers (Fig. 4, lane 15). These
differences in degree and character of Cln2TFT-mediated
phosphorylation were reasonable given that the Sic1 portion
of the GST–Sic1 derivative contains eight CDK consensus
sites while the Sic1ΔP portion of the GST–Sic1ΔP derivative
contains five. The Ime2TFT-containing fraction also catalyzed
GST–Sic1 phosphorylation, but the change in electrophoretic
mobility characteristic of the Cln2TFT-mediated reaction was
not observed (Fig. 4, lane 8). Furthermore, the extent of theted as substrates of the Ime2TFT and Cln2TFT (gal) fractions and the control (glu)
tive phosphate was detected and quantified by phosphorimager analysis (upper
en normalized to the sample containing the uninduced Ime2 enzyme fraction and
e phosphorylated Ime2TFT and Cln2TFT, as shown. GST–Sic1 content in these
Fig. 5. Physical analysis of phosphorylated Sic1 derivatives. (A) Phosphorylated substrates. GST–Sic1 and GST–Sic1ΔP phosphorylation reactions were conducted in
vitro with either Ime2TFT or Cln2TFT fractions. Phosphoproducts were transferred to a PVDF membrane and visualized by phosphorimaging. For Ime2TFT, two
concentrations of enzyme were used (lane 2>lane 1; see Materials and methods) with slight increases in reaction efficiency. Phosphorylated substrates generated
through the two Ime2TFT-mediated reactions were pooled for subsequent analysis. (B) Phosphoamino acid analyses of Ime2TFT- and Cln2TFT–Cdk1-generated
phospho-GST–Sic1. The positions of the phosphoamino acid standards included with the samples during the two-dimensional separation were determined by
ninhydrin staining, and the presence of 32P-labeled phosphoamino acids was determined by phosphorimaging. The lower panel indicates the directions of
electrophoresis and the relative positions of inorganic phosphate (Pi), phosphoserine (P-S), phosphothreonine (P-T), and phosphotyrosine (P-Y). (C) Phosphopeptide
maps of phospho-GST–Sic1 and phospho-GST–Sic1ΔP generated through Ime2TFT or Cln2TFT–Cdk1 catalysis. Tryptic fragments were separated in two dimensions
and visualized by phosphorimaging. The numbers 1–7 refer to the predominant radiolabeled tryptic fragments present in the GST–Sic1 samples (see text for details).
Ovals indicate origins and directions of electrophoresis and TLC are shown. (D) Phosphopeptide map of a sample containing tryptic fragments from both the Ime2TFT-
and Cln2TFT–Cdk1-generated phospho-GST–Sic1 populations analyzed in C.
Fig. 6. Phosphorylation of additional Sic1 mutants. GST–Sic1S145A and
–Sic1S201A were tested as substrates of Ime2TFT in vitro. Radioactive
incorporation was detected by phosphorimaging analysis (upper panel) of
the stained gel (lower panel).
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mediated reaction despite the similar histone H1 kinase
activities of the two enzyme preparations (see Fig. 2).
Strikingly, Ime2TFT-dependent phosphorylation of GST–
Sic1ΔP was nearly identical to that of GST–Sic1 (Fig. 4,
lane 13), indicating that mutation of multiple CDK consensus
sites did not significantly alter recognition by Ime2TFT or an
associated protein kinase. These results suggest that Ime2
directly catalyzes Sic1 phosphorylation but at a different
subset of sites than those recognized by Cln2–Cdk1.
To pursue the hypothesis that the two enzymes recognize
different sites within Sic1, we further analyzed phosphorylated
GST–Sic1 and GST–Sic1ΔP products. Phosphoisomers were
generated in vitro (Fig. 5A) and isolated as described in
Materials and methods. Partial acid hydrolysis of Cln2–Cdk1-
catalyzed phospho-GST–Sic1 yielded phosphoserine andphosphothreonine in nearly equal proportions, as expected
(Fig. 5B, upper right). However, the same treatment of Ime2-
generated phospho-GST-Sic1 yielded phosphoserine almost
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revealed entirely different patterns for the two phosphorylated
products. Tryptic digestion of Cln2–Cdk1-catalyzed phospho-
GST–Sic1 led to a complex map (Fig. 5C, upper right), as
would be expected with a protein phosphorylated at numerous
sites, while tryptic digestion of Ime2-catalyzed phospho-GST–
Sic1 led to only two predominant phosphorylated species (Fig.
5C, upper left). Comparison of the GST–Sic1 maps with the
GST–Sic1ΔP maps revealed obvious differences with Cln2TFT
but not with Ime2TFT. For example, species 4, 5 and 7 generated
through Cln2–Cdk1 catalysis were abolished or greatly
diminished by mutation of Cdk1-targeted phosphorylation
sites (Fig. 5C, right panels), whereas species 1 and 2 generated
through Ime2 catalysis appeared in similar proportions
regardless of Sic1 status (Fig. 5C, left panels). We generated
an additional phosphopeptide map in which the GST–Sic1
phosphopeptides resulting from the two kinase reactions were
mixed (Fig. 5D). Comparison of these data with the original
maps (Fig. 5C, upper panels) clearly indicates that species 2
was unique to the Ime2TFT sample. It is conceivable that
species 1, generated through Ime2 catalysis, and species 5,
generated through Cln2–Cdk1 catalysis, comigrated. However,
species 5 was abolished by mutation of Cdk1 phosphorylation
sites, while species 1 was not (Fig. 5C). Therefore, we would
argue that species 1 and 5 were distinct phosphopeptides.
Taking these physical data together, we suggest that Cln2–
Cdk1 and Ime2 catalyze phosphorylation of different sites
within Sic1.
Our results with Sic1 and Rfa2 indicate that Cdk1 and Ime2
have different specificities. This result is consistent with the
data from a proteomic analysis in which Cln2–Cdk1 and Ime2
were found to catalyze phosphorylation of largely non-
overlapping sets of proteins [28]. However, our results are
not consistent with a very recent report, published during the
course of our studies, in which Ime2 and Cln2–Cdk1 are
reported to recognize overlapping sets of residues within Sic1
in vitro [29]. At this point, we can only speculate as to the
underlying cause of these disparate results, but it could
involve differences in the nature of the reactions, including the
versions of Ime2 and/or Sic1 that were employed, differences
in the method of analysis, or both. As a first step in identifying
the serines that were phosphorylated in our system, we
purified GST–Sic1 containing Sic1 S145A or S201A muta-
tions. These two residues were characterized as Ime2 targets
in vitro in the aforementioned study, along with three
threonines [29], and we expected that S145 would be recog-
nized by Ime2 based on our experiments with Rfa2 [19].
However, neither mutation appeared to affect Ime2TFT-
dependent GST-Sic1 phosphorylation in vitro (Fig. 6).
Consistent with published results [30], the S201A mutation
virtually abolished casein kinase II-catalyzed GST–Sic1
phosphorylation (data not shown). Therefore, S201 was
accessible but not recognized by Ime2 in our system. Further
experiments will be required to determine whether S145 can be
characterized similarly. Regardless, our results suggest that
Ime2 can catalyze phosphorylation of Sic1 serine residues that
were not previously identified as targets in vitro.The differences that we have uncovered between Cdk1 and
Ime2, particularly with respect to Sic1 phosphorylation,
indicate that a current model regarding meiotic destruction
of Sic1 should be modified. It has been reported that meiosis-
specific expression of Sic1ΔP prevents meiotic DNA replica-
tion [11], suggesting that the general mechanism of Sic1
degradation is similar during the cell cycle and during meiosis
except that different kinases catalyze Sic1 phosphorylation.
One possibility, as proposed previously in the literature [10], is
that Ime2 is the Sic1 kinase that promotes Sic1 degradation.
However, our results indicate that Ime2 and Cdk1 recognize
different sites in Sic1. If Sic1 phosphorylation is in fact
important for its degradation and the same sites are involved
as during the cell cycle, we suggest that another protein kinase
downstream of Ime2 directly catalyzes Sic1 phosphorylation
during meiosis. This protein kinase would share the Cdk1
specificity and thereby serve as an effective G1 cyclin–Cdk1
replacement in early meiosis. Future experiments will be
aimed at exploring this possibility and precisely defining the
mechanism by which Ime2 promotes proper S phase entry in
meiosis.
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